10x Genomics Inc.

NASDAQ: TXG · Real-Time Price · USD
13.53
0.29 (2.19%)
At close: Aug 15, 2025, 10:01 AM

10x Genomics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
344.07M 359.28M 219.75M 587.45M
Short-Term Investments
49.34M 29.41M 210.24M n/a
Long-Term Investments
n/a n/a 4.97M 7.6M
Other Long-Term Assets
4.13M 3.06M 7.37M 10.92M
Receivables
87.86M 114.83M 104.21M 85.25M
Inventory
83.11M 73.71M 81.63M 59.97M
Other Current Assets
20.02M 18.79M 19.21M 1.03M
Total Current Assets
584.39M 596.02M 635.03M 747.59M
Property-Plant & Equipment
309.94M 344.93M 359.21M 230.41M
Goodwill & Intangibles
20.18M 21.13M 27.37M 29.91M
Total Long-Term Assets
334.25M 369.12M 393.94M 271.24M
Total Assets
918.64M 965.14M 1.03B 1.02B
Account Payables
12.91M 15.74M 21.6M 17.35M
Deferred Revenue
20.66M 13.15M 7.87M 5.34M
Short-Term Debt
9.29M 11.52M 9.04M 5.13M
Other Current Liabilities
8.49M 40.08M 46.66M 41.16M
Total Current Liabilities
117.63M 127.16M 130.96M 110.36M
Long-Term Debt
n/a 83.85M 86.14M 76.85M
Other Long-Term Liabilities
5.03M 4.28M 6.14M 14.05M
Total Long-Term Liabilities
90.87M 96.94M 92.28M 90.9M
Total Liabilities
208.5M 224.1M 223.24M 201.26M
Total Debt
82.61M 95.37M 95.18M 81.98M
Common Stock
2K 2K 2K 2K
Retained Earnings
-1.47B -1.28B -1.03B -863.32M
Comprehensive Income
-493K -429K -4.33M 22K
Shareholders Equity
710.13M 741.04M 805.74M 817.57M
Total Investments
49.34M 29.41M 210.24M 7.6M